Cancer research and Leica Laser microdissection!

Cancer research and Leica Laser microdissection!

Anatomy - Pathology / Molecular Diagnostics / Cell Biology

December 18, 2018

DNA mutations lead to abnormal or missing functional proteins, which can cause cells to multiply uncontrollably and become cancerous. The extraction of pure tumor material is extremely important to understand the underlying mutation for a specific cancer type.

Leica Laser Microdissection systems allows the extraction of purely cancerous tissue without contaminating your sample with healthy cells and improve the workflow by precisely cutting only the cells you are interested in.

  • Every step is done under visual control and proceeds without contamination with surrounding tissue.

  • A New LMD software 8.2 with improved usability and larger application range.

  • A powerful and easy-to-use software that contains all needed features for a successful laser microdissection process enabling the user to easily select, dissect and visualize dissectates.

RIDAQUICK Gliadin - approved by AOAC

RIDAQUICK Gliadin - approved by AOAC

Anatomy - Pathology / Molecular Diagnostics / Cell...

R-biopharm is proud to announce that lateral flow test for gluten analysis is now approved by one of the most important organizations for method validation. The dip stick RIDA®QUICK Gliadin was approved by the AOAC Performance Tested Methods (SM) Program and was assigned PTM Certification No. 101702 by the AOAC Research Institute.

November 09, 2017 More +
Chronic Lymphocytic Leukemia CLL Product release

Chronic Lymphocytic Leukemia CLL Product release

Anatomy - Pathology / Molecular Diagnostics / Cell...

Multiplicom is pleased to announce the release of the new CLL MASTR Plus, a RUO assay for identification of mutations in the coding regions of 9 genes related to CLL.

June 03, 2015 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us